1. Home
  2. QNCX vs SANG Comparison

QNCX vs SANG Comparison

Compare QNCX & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$2.81

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

N/A

Current Price

$5.01

Market Cap

170.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
QNCX
SANG
Founded
2012
1984
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
170.0M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
QNCX
SANG
Price
$2.81
$5.01
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$7.67
N/A
AVG Volume (30 Days)
698.3K
3.7K
Earning Date
11-12-2025
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$227,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$4.08
52 Week High
$4.55
$7.99

Technical Indicators

Market Signals
Indicator
QNCX
SANG
Relative Strength Index (RSI) 38.83 46.23
Support Level $3.18 $4.80
Resistance Level $3.38 $5.08
Average True Range (ATR) 0.27 0.14
MACD -0.17 -0.02
Stochastic Oscillator 6.51 39.62

Price Performance

Historical Comparison
QNCX
SANG

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

Share on Social Networks: